Predictive factors for prolonged survival in recurrent endometrial carcinoma: Implications for follow-up protocol

Gynecologic Oncology

Volumn 119, Issue 3, 2010, Pages 506-510

  Otsuka, Isao ^a   Uno, Masaya ^b,c   Wakabayashi, Akira ^b   Kameda, Shogo ^a   Udagawa, Hideo ^c   Kubota, Toshiro ^b  

^a KAMEDA MEDICAL CENTER   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY HOSPITAL   (Japan)

^c ASAHI GENERAL HOSPITAL   (Japan)

Author keywords

Endometrial carcinoma; Follow up; Predictive factor; Recurrence

Indexed keywords

CA 125 ANTIGEN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS; VAGINA CYTOLOGY;

AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CARCINOMA, ENDOMETRIOID; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 78149359449     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.08.013     Document Type: Article

References (21)

1. C.P. Morrow, B.N. Bundy, R.J. Kurman, W.T. Creasman, P. Heller, and H.D. Homesley Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group Study Gynecol Oncol 40 1991 55 65
2. National Cancer Center. Cancer statistics; 2010 (http://ganjoho.jp/ public/statistics/pub/nenji.html ).
3. E. Podczaski, P. Kaminski, K. Gurski, C. MacNeill, J.A. Stryker, and K. Singapuri Detection and patterns of treatment failure in 300 consecutive cases of "early " endometrial cancer after primary surgery Gynecol Oncol 47 1992 323 327
4. A. Berchuck, C. Anspach, A.C. Evans, J.T. Soper, G.C. Rodriguez, and R. Dodge Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma Gynecol Oncol 59 1995 20 22
5. J.M. Reddoch, T.W. Burke, M. Morris, C. Tornos, C. Levenback, and D.M. Gershenson Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme Gynecol Oncol 59 1995 221 225
6. A. Gadducci, S. Cosio, A. Fanucchi, R. Cristofani, and A.R. Genezzani An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer Anticancer Res 20 2000 1977 1984
7. J.P. Connor, J.I. Andrews, B. Anderson, and R.E. Buller Computed tomography in endometrial carcinoma Obstet Gynecol 95 2000 692 696
8. I. Otsuka, T. Kubota, and T. Aso Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy Br J Cancer 87 2002 377 380
9. J.D. Morgan III, S. Reddy, P. Sarin, E. Yordan, K. DeGeest, and F.R. Hendrickson Isolated vaginal recurrences of endometrial carcinoma Radiology 189 1993 609 613
10. J.D. Sears, K.M. Greven, H.M. Hoen, and M.E. Randall Prognsotic factors and treatment outcome for patients with locally recurrent endometrial cancer Cancer 74 1994 1303 1308
11. C.J. Smith, M. Heeren, J.L. Nicklin, L.C. Perrin, R. Land, and A.J. Crandon Efficacy of routine follow-up in patients with recurrent uterine cancer Gynecol Oncol 107 2007 124 129
12. R.E. Bristow, A. Santillan, M.L. Zahurak, G.J. Gardner, R.L. Giuntoli II, and D.K. Armstrong Salvage cytoreductive surgery for recurrent endometrial cancer Gynecol Oncol 103 2006 281 287
13. A.G. Shumsky, G.C.E. Stuart, P.M. Brasher, J.G. Nation, D.I. Robertson, and S. Sangkarat An evaluation of routine follow-up of patients treated for endometrial carcinoma Gynecol Oncol 55 1994 229 233
14. P. Owen, and I.D. Duncan Is there any value in the long term follow up of women treated for endometrial cancer? Br J Obstet Gynaecol 103 1996 710 713
15. M. Fung-Kee-Fung, J. Dodge, L. Elit, H. Lukka, A. Chambers, and T. Oliver Follow-up after primary therapy for endometrial cancer: A systematic review Gynecol Oncol 101 2006 520 529
16. C.L. Creutzberg, W.L.J. van Putten, P.C. Koper, M.L.M. Lybeert, J.J. Jobsen, and C.C. Warlam-Rodenhius for the PORTEC Study Group. Survival after relapse in patients with endometrial cancer: results from a randomized trial Gynecol Oncol 89 2003 201 209
17. J. Wylie, C. Irwin, M. Pintilie, W. Levic, L. Manchul, and M. Milosevic Results of radical radiotherapy for recurrent endometrial cancer Gynecol Oncol 77 2000 66 72
18. I. Otsuka, I. Ono, H. Akamatsu, K. Sunamori, and T. Aso Pulmonary metastasis from endometrial carcinoma Int J Gynecol Cancer 12 2002 208 213
19. E. Campagnutta, G. Giorda, G. De Piero, F. Sopracodevole, M.C. Visentin, and L. Martella Surgical treatment of recurrent endometrial carcinoma Cancer 100 2004 89 96
20. P. Morice, C. Levy-Piedbois, S. Ajaj, P. Pautier, C. Haie-Meder, and C. Lhomme Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer Eur J Cancer 37 2001 985 990
21. W.A.A. Tjalma, P.A. van Dam, A.P. Makar, and D.J. Cruickshank The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients Int J Gynecol Cancer 14 2004 931 937